CN107998304A - A kind of medicine and preparation method for treating lung cancer - Google Patents

A kind of medicine and preparation method for treating lung cancer Download PDF

Info

Publication number
CN107998304A
CN107998304A CN201810078772.5A CN201810078772A CN107998304A CN 107998304 A CN107998304 A CN 107998304A CN 201810078772 A CN201810078772 A CN 201810078772A CN 107998304 A CN107998304 A CN 107998304A
Authority
CN
China
Prior art keywords
parts
lung cancer
medicine
stem
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810078772.5A
Other languages
Chinese (zh)
Inventor
杜成秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810078772.5A priority Critical patent/CN107998304A/en
Publication of CN107998304A publication Critical patent/CN107998304A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/78—Saururaceae (Lizard's-tail family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8984—Dendrobium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of medicine and preparation method for treating lung cancer, drug component includes 10 20 parts of reed root in parts by weight, 5 18 parts of lily, 10 20 parts of Radix Salviae Miltiorrhizae, 4 12 parts of cordate houttuynia, 6 16 parts of American Ginseng, white 5 10 parts of book, 4 12 parts of walnut kernel, 9 18 parts of subprostrate sophora, 39 parts of indian adenosma herb, 4 10 parts of Fructus Malvae Vertillatae, 5 15 parts of stachyurus pith, 8 18 parts of Stenoloma chusana, 6 16 parts of rabdosia lophanthide, 5 12 parts of cassia twig, 3 10 parts of the stem of noble dendrobium, 4 12 parts of dandelion, preparation method of the present invention is simple, obtained medicine can effectively suppress growth of cancer cells, patient, which can be reduced, is receiving chemotherapy at the same time, the injury that normal structure is subject to during radiotherapy, improve the cure rate of patients with lung cancer, reduce the death rate.

Description

A kind of medicine and preparation method for treating lung cancer
Technical field
The present invention relates to pharmaceutical technology field, is specially a kind of medicine and preparation method for treating lung cancer.
Background technology
Lung cancer is one of common malignant tumour, can be divided into primary lung cancer, Secondary cases lung cancer by clinical classification.It is near tens of Year, the morbidity and mortality of lung cancer had the trend substantially increased, and the morbidity and mortality of lung cancer rise rapidly, this It is a worldwide trend.In Shanghai, Jiangsu and Zhejiang Provinces area, the incidence of lung cancer is 3 ‰, no matter masculinity femininity, lung cancer is all first The cause of death of position cancer, 5 years survival rates of lung cancer are still not less than 10%.
The treatment means of lung cancer mainly have operation, radiotherapy, chemotherapy and the molecular targeted therapy and Traditional Chinese Medicine occurred recently The auxiliary treatment of Chinese medicine, but the therapeutic effect of lung cancer is still very unsatisfactory so far；The traditional Chinese medical science regards lung cancer as complete One topical manifestations of body disease, emphasize across-the-board regulation function of human body in treatment, by dialectical with for cancer.Due to the disease of lung cancer Because the interpretation of the cause, onset and process of an illness is complicated, a set of generally acknowledged differentiation of symptoms and signs for classification of syndrome standard is not yet made at present, and most scholar is still distinguished by respective understanding angle Demonstrate,prove parting and prescription medicine.Comprehensive lung cancer card type, tends to be divided into insufficiency of the spleen phlegm wet at present, phlegm-blood stasis stagnates, qi depression to blood stasis, the moon mostly Heat in void, deficiency of both qi and yin, lung kidney deficiency are lost and the card type such as yin-yang deficiency.Specific method has Qi-Yin supplementing therapy, tonification and purgation in combination method etc..Mesh The medicine of preceding use can not effectively suppress the growth of cancer cell, and side effect is big.
The content of the invention
It is an object of the invention to provide a kind of medicine and preparation method for treating lung cancer, to solve in above-mentioned background technology The problem of proposition.
To achieve the above object, the present invention provides following technical solution：A kind of medicine for treating lung cancer, drug component is by weight Measuring number includes 10-20 parts of reed root, 5-18 parts of lily, 10-20 parts of Radix Salviae Miltiorrhizae, 4-12 parts of cordate houttuynia, 6-16 parts of American Ginseng, white book 5- 10 parts, 4-12 parts of walnut kernel, 9-18 parts of subprostrate sophora, 3-9 parts of indian adenosma herb, 4-10 parts of Fructus Malvae Vertillatae, 5-15 parts of stachyurus pith, Stenoloma chusana 8-18 Part, 6-16 parts of rabdosia lophanthide, 5-12 parts of cassia twig, 3-10 parts of the stem of noble dendrobium, 4-12 parts of dandelion.
Preferably, the preferable composition proportion of drug component includes 15 parts of reed root, 12 parts of lily, 15 parts of Radix Salviae Miltiorrhizae, cordate houttuynia 8 Part, 11 parts of American Ginseng, 8 parts of white book, 8 parts of walnut kernel, 14 parts of subprostrate sophora, 6 parts of indian adenosma herb, 7 parts of Fructus Malvae Vertillatae, 10 parts of stachyurus pith, crow 13 parts of fragrant-flowered garlic, 11 parts of rabdosia lophanthide, 9 parts of cassia twig, 7 parts of the stem of noble dendrobium, 8 parts of dandelion.
Preferably, its preparation method comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A being added in grinder and ground, grinding rate is 200-500 revs/min, powdered up to being ground to, Obtain mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Compared with prior art, the beneficial effects of the invention are as follows：Preparation method of the present invention is simple, and obtained medicine can have Effect suppresses growth of cancer cells, while can reduce patient's injury that normal structure is subject to when receiving chemotherapy, radiotherapy, improves lung The cure rate of cancer patient, reduces the death rate；The present invention acts on lung, the heart, has effects that detumescence, moistening lung, resolving sputum, cough-relieving, to cancer Cell has very strong inhibitory action.While cancer cell is suppressed, constitution is also lifted, is invigorated the spleen and benefited qi, nourishing blood and tranquilization is to improve Patient's resistance, has the function that to treat both principal and secondary aspect of disease.
Embodiment
The technical solution in the embodiment of the present invention is clearly and completely described below, it is clear that described embodiment Only part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, the common skill in this area Art personnel all other embodiments obtained without making creative work, belong to the model that the present invention protects Enclose.
The present invention provides following technical solution：A kind of medicine for treating lung cancer, drug component include reed root in parts by weight 10-20 parts, 5-18 parts of lily, 10-20 parts of Radix Salviae Miltiorrhizae, 4-12 parts of cordate houttuynia, 6-16 parts of American Ginseng, book 5-10 parts white, walnut kernel 4- 12 parts, 9-18 parts of subprostrate sophora, 3-9 parts of indian adenosma herb, 4-10 parts of Fructus Malvae Vertillatae, 5-15 parts of stachyurus pith, 8-18 parts of Stenoloma chusana, rabdosia lophanthide 6-16 Part, 5-12 parts of cassia twig, 3-10 parts of the stem of noble dendrobium, 4-12 parts of dandelion.
Embodiment one：
Drug component in parts by weight include 10 parts of reed root, 5 parts of lily, 10 parts of Radix Salviae Miltiorrhizae, 4 parts of cordate houttuynia, 6 parts of American Ginseng, White 5 parts of book, 4 parts of walnut kernel, 9 parts of subprostrate sophora, 3 parts of indian adenosma herb, 4 parts of Fructus Malvae Vertillatae, 5 parts of stachyurus pith, 8 parts of Stenoloma chusana, 6 parts of rabdosia lophanthide, 5 parts of cassia twig, 3 parts of the stem of noble dendrobium, 4 parts of dandelion.
The preparation method of the present embodiment comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A is added in grinder and ground, grinding rate is 200 revs/min, powdered up to being ground to, and is obtained Mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Embodiment two：
Drug component includes 20 parts of reed root, 18 parts of lily, 20 parts of Radix Salviae Miltiorrhizae, 12 parts of cordate houttuynia, American Ginseng 16 in parts by weight Part, 10 parts of white book, 12 parts of walnut kernel, 18 parts of subprostrate sophora, 9 parts of indian adenosma herb, 10 parts of Fructus Malvae Vertillatae, 15 parts of stachyurus pith, 18 parts of Stenoloma chusana, small stream 16 parts of yellow grass, 12 parts of cassia twig, 10 parts of the stem of noble dendrobium, 12 parts of dandelion.
The preparation method of the present embodiment comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A is added in grinder and ground, grinding rate is 500 revs/min, powdered up to being ground to, and is obtained Mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Embodiment three：
Drug component in parts by weight include 12 parts of reed root, 7 parts of lily, 12 parts of Radix Salviae Miltiorrhizae, 5 parts of cordate houttuynia, 7 parts of American Ginseng, White 6 parts of book, 5 parts of walnut kernel, 10 parts of subprostrate sophora, 4 parts of indian adenosma herb, 5 parts of Fructus Malvae Vertillatae, 7 parts of stachyurus pith, 9 parts of Stenoloma chusana, 7 parts of rabdosia lophanthide, 7 parts of cassia twig, 4 parts of the stem of noble dendrobium, 5 parts of dandelion.
The preparation method of the present embodiment comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A is added in grinder and ground, grinding rate is 250 revs/min, powdered up to being ground to, and is obtained Mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Example IV：
Drug component includes 18 parts of reed root, 16 parts of lily, 18 parts of Radix Salviae Miltiorrhizae, 10 parts of cordate houttuynia, American Ginseng 15 in parts by weight Part, 9 parts of white book, 11 parts of walnut kernel, 16 parts of subprostrate sophora, 8 parts of indian adenosma herb, 9 parts of Fructus Malvae Vertillatae, 13 parts of stachyurus pith, 16 parts of Stenoloma chusana, small stream are yellow 15 parts of grass, 10 parts of cassia twig, 9 parts of the stem of noble dendrobium, 10 parts of dandelion.
The preparation method of the present embodiment comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A is added in grinder and ground, grinding rate is 450 revs/min, powdered up to being ground to, and is obtained Mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Embodiment five：
Drug component includes 14 parts of reed root, 14 parts of lily, 16 parts of Radix Salviae Miltiorrhizae, 9 parts of cordate houttuynia, American Ginseng 12 in parts by weight Part, 9 parts of white book, 5 parts of walnut kernel, 13 parts of subprostrate sophora, 8 parts of indian adenosma herb, 8 parts of Fructus Malvae Vertillatae, 12 parts of stachyurus pith, 10 parts of Stenoloma chusana, small stream are yellow 12 parts of grass, 9 parts of cassia twig, 8 parts of the stem of noble dendrobium, 10 parts of dandelion.
The preparation method of the present embodiment comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A is added in grinder and ground, grinding rate is 280 revs/min, powdered up to being ground to, and is obtained Mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Embodiment six：
Drug component includes 15 parts of reed root, 12 parts of lily, 15 parts of Radix Salviae Miltiorrhizae, 8 parts of cordate houttuynia, American Ginseng 11 in parts by weight Part, 8 parts of white book, 8 parts of walnut kernel, 14 parts of subprostrate sophora, 6 parts of indian adenosma herb, 7 parts of Fructus Malvae Vertillatae, 10 parts of stachyurus pith, 13 parts of Stenoloma chusana, small stream are yellow 11 parts of grass, 9 parts of cassia twig, 7 parts of the stem of noble dendrobium, 8 parts of dandelion.
The preparation method of the present embodiment comprises the following steps：
A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, small Add in frying pan and stir-fry after the stem pith of the rice-paper plant, Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, using being used after being stirred by slow fire 10min High fire stir-frying 5min, is cooled to room temperature, obtains mixture A afterwards；
B, mixture A is added in grinder and ground, grinding rate is 350 revs/min, powdered up to being ground to, and is obtained Mixture B；
C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
Model case
Case 1：Poplar, man, 62 years old.Patient's dry cough, become thin, and lung cancer is diagnosed as through CT examination in local hospital, using this The medicine of invention is treated, and after 5 courses for the treatment of, patient symptom substantially mitigates.Continue to take 2 courses for the treatment of, patient's focal symptom is complete It totally disappeared mistake, follow-up 1 year is without recurrence.
Case 2：Lee, man, 78 years old.Patient has vicennial smoking history.Occur cough, blood-stained sputum in this year, The symptoms such as chest pain, inspection are diagnosed as lung cancer.Through taking medicine of the present invention, after 8 courses for the treatment of, patient symptom substantially mitigates, and continues to take With 7 courses for the treatment of, patient's focal symptom is wholly absent, and follow-up 1 year is without recurrence.
Preparation method of the present invention is simple, and obtained medicine can effectively suppress growth of cancer cells, while can reduce patient The injury that normal structure is subject to when receiving chemotherapy, radiotherapy, improves the cure rate of patients with lung cancer, reduces the death rate；The present invention Lung, the heart are acted on, there is detumescence, moistening lung, resolving sputum, cough-relieving, there is very strong inhibitory action to cancer cell.Suppressing, cancer is thin While born of the same parents, constitution is also lifted, is invigorated the spleen and benefited qi, nourishing blood and tranquilization has the function that to treat both principal and secondary aspect of disease to improve patient's resistance.
Although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with Understanding without departing from the principles and spirit of the present invention can carry out these embodiments a variety of changes, modification, replace And modification, the scope of the present invention is defined by the appended.

Claims (3)

  1. A kind of 1. medicine for treating lung cancer, it is characterised in that：Drug component includes 10-20 parts of reed root, lily 5- in parts by weight 18 parts, 10-20 parts of Radix Salviae Miltiorrhizae, 4-12 parts of cordate houttuynia, 6-16 parts of American Ginseng, book 5-10 parts white, 4-12 parts of walnut kernel, subprostrate sophora 9-18 Part, 3-9 parts of indian adenosma herb, 4-10 parts of Fructus Malvae Vertillatae, 5-15 parts of stachyurus pith, 8-18 parts of Stenoloma chusana, 6-16 parts of rabdosia lophanthide, 5-12 parts of cassia twig, 3-10 parts of the stem of noble dendrobium, 4-12 parts of dandelion.
  2. A kind of 2. medicine for treating lung cancer according to claim 1, it is characterised in that：The preferable composition proportion of drug component Including 15 parts of reed root, 12 parts of lily, 15 parts of Radix Salviae Miltiorrhizae, 8 parts of cordate houttuynia, 11 parts of American Ginseng, 8 parts of white book, 8 parts of walnut kernel, subprostrate sophora 14 parts, 6 parts of indian adenosma herb, 7 parts of Fructus Malvae Vertillatae, 10 parts of stachyurus pith, 13 parts of Stenoloma chusana, 11 parts of rabdosia lophanthide, 9 parts of cassia twig, 7 parts of the stem of noble dendrobium, Pu Gong 8 parts of English.
  3. 3. realize a kind of preparation method of medicine for treating lung cancer described in claim 1, it is characterised in that：Its preparation method bag Include following steps：
    A, by reed root, lily, Radix Salviae Miltiorrhizae, cordate houttuynia, American Ginseng, Bai Shu, walnut kernel, subprostrate sophora, indian adenosma herb, Fructus Malvae Vertillatae, stachyurus pith, Add in frying pan and stir-fry after Stenoloma chusana, rabdosia lophanthide, cassia twig, the stem of noble dendrobium, dandelion mixing, it is fiery using height after 10min using being stirred by slow fire Stir-fry 5min, is cooled to room temperature afterwards, obtains mixture A；
    B, mixture A is added in grinder and ground, grinding rate is 200-500 revs/min, powdered up to being ground to, and is obtained Mixture B；
    C, filling, obtained capsule is carried out after mixture B being used 80 mesh screens.
CN201810078772.5A 2018-01-26 2018-01-26 A kind of medicine and preparation method for treating lung cancer Pending CN107998304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810078772.5A CN107998304A (en) 2018-01-26 2018-01-26 A kind of medicine and preparation method for treating lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810078772.5A CN107998304A (en) 2018-01-26 2018-01-26 A kind of medicine and preparation method for treating lung cancer

Publications (1)

Publication Number Publication Date
CN107998304A true CN107998304A (en) 2018-05-08

Family

ID=62066242

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810078772.5A Pending CN107998304A (en) 2018-01-26 2018-01-26 A kind of medicine and preparation method for treating lung cancer

Country Status (1)

Country Link
CN (1) CN107998304A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105687450A (en) * 2016-03-24 2016-06-22 青岛大学附属医院 Medicament capable of treating lung cancer by virtue of combined treatment of traditional Chinese medicine and western medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105687450A (en) * 2016-03-24 2016-06-22 青岛大学附属医院 Medicament capable of treating lung cancer by virtue of combined treatment of traditional Chinese medicine and western medicine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张文怡: "中医扶正培本法辅助肿瘤化疗47例", 《中医药临床杂志》 *
郑黎明等: "郑玉麒老中医肺癌论治", 《中西医结合研究》 *

Similar Documents

Publication Publication Date Title
CN101229266B (en) Medicine for curing psoriasis
CN102247586A (en) Medicine for treating asthma and preparation method thereof
CN102764371B (en) Traditional Chinese medicine compound prescription for relieving radiotherapy side reactions and preparation method and application thereof
TWI840312B (en) A chinese medicinal composition and its application
CN102526611A (en) Chinese medicinal composition for treating chronic heart failure
CN107998304A (en) A kind of medicine and preparation method for treating lung cancer
CN102657839B (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN107929545A (en) A kind of Chinese medicine compound prescription for treating Small pulmonary nodule
CN104826075B (en) A kind of Chinese medicine for treating intractable headache
CN104435545B (en) A kind of Chinese medicine preparation for treating caused by benzene leukopenia
CN102512518B (en) Chinese medicinal extract for treating diabetic peripheral neuropathy and preparation method thereof
CN101530595B (en) Thrombolysis decoction for treating cardiovascular diseases
CN116617299B (en) Traditional Chinese medicine composition for treating allergic rhinitis and application thereof
CN109908294B (en) Pharmaceutical composition for treating stable stage of bronchiectasis and preparation method and application thereof
CN116570699B (en) Traditional Chinese medicine composition for treating pulmonary nodules as well as preparation and application thereof
CN103028088B (en) Traditional Chinese medicine composition for treating coronary heart disease and angina
CN101983712A (en) Novel medicament for treating coronary heart disease
CN106177561A (en) One treats phthisical Chinese medicine composition
CN106581531A (en) Drug for treating foot sweating and foot odor
CN106266307B (en) Ant bear gall pill and its preparation method and application
CN105582187A (en) Traditional Chinese medicine composition formula for preventing and treating allergic dermatitis
CN104107242A (en) Traditional Chinese medicinal composition for treating hyperthyroidism, and preparation method and application thereof
CN104623465A (en) Cooperation application of traditional Chinese medicine to treatment of mycobacteria infection
CN104189846A (en) Traditional Chinese medicine composition used as radiotherapy and chemotherapy sensitizing agent and preparation method thereof
CN104474184A (en) Medicine for treating postinfectious cough

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180508

RJ01 Rejection of invention patent application after publication